AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.05
+0.15 (3.06%)
At close: Sep 18, 2026, 4:00 PM EDT
5.04
-0.01 (-0.20%)
After-hours: Sep 18, 2026, 7:30 PM EDT
AN2 Therapeutics Employees
AN2 Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 1 or -4.55% compared to the previous year.
Employees
21
Change (1Y)
-1
Growth (1Y)
-4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,727,429
Market Cap
190.57M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | -1 | -4.55% | 21 | 0 |
| Dec 31, 2024 | 22 | -19 | -46.34% | 22 | 0 |
| Dec 31, 2023 | 41 | 5 | 13.89% | 41 | 0 |
| Mar 31, 2023 | 36 | 14 | 63.64% | 35 | 1 |
| Dec 31, 2022 | 36 | 14 | 63.64% | 35 | 1 |
| Sep 30, 2022 | 27 | 5 | 22.73% | 26 | 1 |
| Jun 30, 2022 | 25 | - | - | 25 | 0 |
| Mar 31, 2022 | 22 | - | - | 22 | 0 |
| Dec 31, 2021 | 22 | - | - | 22 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Nkarta | 106 |
| Alpha Cognition | 71 |
| Acumen Pharmaceuticals | 61 |
| PepGen | 57 |
| Korro Bio | 57 |
| Surrozen | 44 |
| Sol-Gel Technologies | 28 |
ANTX News
- 3 days ago - AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - AN2 Therapeutics presents clinical data supporting development of Epetraborole - TheFly
- 19 days ago - AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - Business Wire
- 26 days ago - AN2 Therapeutics appoints Trenor as Chief Medical Officer - TheFly
- 26 days ago - AN2 Therapeutics Appoints Cameron Trenor, M.D., as Chief Medical Officer - Business Wire
- 5 weeks ago - AN2 Therapeutics reports Q2 EPS (18c), two estimates (24c) - TheFly
- 5 weeks ago - AN2 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights - Business Wire
- 5 weeks ago - AN2 Therapeutics Earnings release: Q2 2026 - Filings